Industry Perceptions and Expectations - The Role of ICER as an Independent HTA

Presented by

Mike Pace, Sr. Principal, Global Pricing & Market Access; Nathan White, Senior Vice President, Integrated Access & Outcomes

About this talk

This webinar explores: - The evolution of health technology assessment in the US and possibilities for the future - Opinions of manufacturers and US payer stakeholders on the role of - - ICER in the US healthcare system, as learned through a primary research study of more than 50 participants ICER methodologies and approaches to evaluation of clinical and health economic evidence - Ways manufacturers can begin to more proactively prepare for an ICER assessment

Related topics:

More from this channel

Upcoming talks (0)
On-demand talks (35)
Subscribers (483)
BioPharma companies and Medical Devices manufacturers face growing operational, regulatory and economic challenges when it comes to developing their drug or device. ICON provides analysis and key insights on these challenges, with practical advice and recommendations.